David Samuel Mathai

Resident Physician

Resident Physician: The Menninger Department of Psychiatry and Behavioral Sciences
Baylor College of Medicine
Houston, TX

BS from Texas A&M University: 12/2012 - College Station; Biochemistry, Genetics

AAAP Travel Award: The American Academy of Addiction Psychiatry (01/2016 - 12/2016)

APA Research Colloquium Junior Investigator Award: American Psychiatric Association

Robert and Sara Jane White Scholarship: American Group Psychotherapy Association

"Just One Bad High:" Considering Synthetic Cannabinoid Outcome Expectancies in Adolescents. " ;
Paradoxical increase in synthetic cannabinoid emergency-related presentations after city wide ban: Lessons from Houston, Texas. " ;
Ketamine and other glutamate agents. " 2017 May ;
Childhood maltreatment and posttraumatic stress disorder. " ;
Borderline personality disorder and a spectrum of trauma. " ;
Persistent and long-term neuropsychiatric implications of cannabis use in adolescents. " AJP Resident's Journal. 2017 Jun ;
Guanfacine attenuates adverse effects of dronabinol (THC) on working memory in adolescent-onset heavy cannabis users: a pilot study. " ;
Revisiting the hallucinogenic potential of ketamine " ;
Recovery from impaired working memory performance during chronic Δ-9-tetrahydrocannabinol administration to adolescent rhesus monkeys. " ;
The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review. " ;
Use of guanfacine for cannabis use disorder and related symptomatology. " ;
S100 inhibitors – A new paradigm for treating Alzheimer’s disease. " ;